Bellevue Asset Management, LLC Global Blood Therapeutics, Inc. Transaction History

Bellevue Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$25.68 - $35.59 $205 - $284	-8 Reduced 16.67%	40 $1,000
Q4 2021 Feb 03, 2022	SELL	$24.9 - $40.26 $99 - $161	-4 Reduced 7.69%	48 $1,000
Q2 2021 Aug 09, 2021	SELL	$32.46 - $43.42 $162 - $217	-5 Reduced 8.77%	52 $2,000
Q1 2021 May 12, 2021	SELL	$38.94 - $50.85 $233 - $305	-6 Reduced 9.52%	57 $2,000
Q4 2020 Feb 11, 2021	BUY	$37.65 - $63.77 $75 - $127	2 Added 3.28%	63 $3,000
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $1,055 - $1,489	20 Added 48.78%	61 $3,000
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $834 - $1,744	20 Added 95.24%	41 $3,000
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $959 - $1,719	21 New	21 $2,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.